C5 Congress: Patenting natural products after Myriad


Speaking at Wednesday's C5 Congress on Biotech and Pharma Patenting in London, Michael McGraw, a partner from Fitzpatrick, Cella, Harper and Scinto in New York, considered the line that separates natural and man-made products.

biotech, pharma, patent, myriad, man-made products, natural products